Public offer to the shareholders of Recipharm AB – SEK 25.0 billion

Carnegie acted as financial adviser to the Board of Directors of Recipharm in EQT’s (via Roar BidCo) public offer to Recipharm’s shareholders. Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees.
February 2021.